Trenchant BioSystems has released internal and external data confirming its [...]

Neuraxpharm has launched two new treatments for attention deficit hyperactivity [...]

Swiss biotech startup FluoSphera has raised €1.23 million (CHF 1.15 [...]

Nucleome Therapeutics has nominated its first preclinical development candidate, marking [...]

Dan Beaudry, market owner for risk-based quality management (RBQM) at [...]

Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]

The UK’s General Pharmaceutical Council (GPhC) has formally recognised Oushk [...]

The age-related macular degeneration market across the seven major markets [...]

Confo Therapeutics has selected CFTX-2034, an SSTR5 agonist antibody, as [...]

AstraZeneca has received a positive recommendation from the Committee for [...]